Extralevator Abdominoperineal Resection for Low Rectal Cancer

Mulsow, Jürgen; Winter, D. C.

doi:10.1001/archsurg.2010.174

Cited by 13 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Various studies have shown better short-term oncological outcomes compared to standard APE. 7,8 The advantage of the ELAPE procedure lies in the reduction of intraoperative perforation (IOP) and positive circumferential margin (CRM) when compared to conventional APE. This is mainly due to the better visibility of surgical planes since patients are in a prone position during the surgery.…”

Section: Introductionmentioning

confidence: 99%

Extralevator abdominoperineal excision for low rectal cancer: oncological outcome after five-year follow-up

et al. 2021

View full text Add to dashboard Cite

BACKGROUND: Extralevator abdominoperineal excision (ELAPE) is a surgical technique that is indicated for low rectal cancer where sphincter preservation is not possible. Compared to conventional abdominoperineal excision major advantages of ELAPE are the risk reduction of intraoperative bowel perforation and positive circumferential margin which lead to a better oncological outcome. The aim of this study was to present our results in ELAPE surgery METHODS: From February 2011 to February 2015, 40 patients underwent surgery for low rectal cancer at the Oncology Institute of Vojvodina. The collected data included sex, age, preoperative staging, neoadjuvant treatment, operative time, rate of intraoperative bowel perforation, rate of positive circumferential resection margins, histopathological analysis, postoperative mortality, tumour, node and metastasis (TNM) classification, local recurrence (LR) rate and presence of distant metastases RESULTS: Positive circumferential margin was found in three (7.5%) patients while eight (20%) patients had intraoperative bowel perforation. LR during follow-up was seen in seven (17.5%) patients, three of them had intraoperative bowel perforation and two patients had positive circumferential margin. The estimated five-year cumulative incidence of LR is 7%. Distant metastases occurred in 18 (45%) patients. The estimated five-year survival rate is 62% CONCLUSION: The study shows satisfactory five-year survival rates of 62% in a highly complex patient group treated by ELAPE procedure Keywords: rectal cancer, extralevator abdominoperineal excision, local recurrence, overall survival

show abstract

Section: Introductionmentioning

confidence: 99%

Extralevator abdominoperineal excision for low rectal cancer: oncological outcome after five-year follow-up

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Extralevator abdominoperineal excision (ELAPE) is a relatively new surgical technique for low rectal cancers. Different studies have shown improved short term oncological outcomes compared to conventional abdominoperineal excision (APE) [1] . For low rectal cancers anterior resection (AR) is the preferred procedure.…”

Section: Introductionmentioning

confidence: 99%

Extralevator abdominoperineal excision (Elape): A retrospective cohort study

Hanif

Bradley²,

Hammad

et al. 2016

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

IntroductionExtralevator abdominoperineal excision (ELAPE) is relatively new surgical technique for low rectal cancers. It is a more radical approach than conventional abdominoperineal excision (APE) with potentially better oncological outcome. The aim of this study was to analyse short term results of ELAPE compared with conventional abdominoperineal excision.MethodsData were collected prospectively for 72 patients who underwent abdominoperineal excision (APE) for low rectal carcinomas from 2010 to 2014. Of these 24 patients underwent ELAPE with biological prosthetic mesh used to close the perineal defect.ResultsThe median age of patients was 68 (37–87). Positive circumferential resection margin (1/24 vs. 8/48) and Intra operative perorations (0/24 vs. 6/48) compared favourably with ELAPE.ConclusionsShort term results from this study support that ELAPE has better oncological outcome.

show abstract